US Stock MarketDetailed Quotes

TLPH Talphera

Watchlist

0.939
+0.018+1.99%

Close Oct 31 16:00 ET

15.95MMarket Cap-2085P/E (TTM)

Talphera Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Talphera Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	-- / 0.000	--
Aug 14, 2024	2024/Q2	0.000 / 0.000	--
May 14, 2024	2024/Q1	0.000 / 0.000	--
Mar 6, 2024	2023/Q4	281.000K / 140.500K	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q3-- / 0.000--

Aug 14, 20242024/Q20.000 / 0.000--

May 14, 20242024/Q10.000 / 0.000--

Mar 6, 20242023/Q4281.000K / 140.500K--

Unlock Free Earnings Estimates

Open Account

Talphera Earnings Reports

Talphera | 10-Q: Q2 2024 Earnings Report

Aug 14 16:17 ET

Talphera | 10-Q: Q1 2024 Earnings Report

May 14 17:06 ET

Talphera | 10-K: FY2023 Annual Report

Mar 6 17:06 ET

AcelRx Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

Nov 14, 2023 06:07 ET

Analyst Rating

Updated: Oct 31, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall